The inauguration of Japanese drug major Takeda's new, state-of-the-art filling line at its Neuchâtel, Switzerland, production ...

Indian drugmaker Biocon has announced the signing of an out-licensing agreement with Ajanta Pharma to market its vertically ...

Against the backdrop of a turbulent year marked by both breakthrough and setbacks, the biopharmaceutical industry is entering ...

The share of imported drugs in the Russian pharmaceutical market should significantly decline over the next six years, while ...

A privately held biopharmaceutical company based in the United States. Its development and planned commercialization ...

Chinese biotech Hutchmed today announces that the New Drug Application (NDA) for fanregratinib (HMPL-453) for the treatment of adult patients with advanced, metastatic or unresectable intrahepatic ...

As many people consider lifestyle changes at the start of the year, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is urging the public to make sure any weight-loss medicines they ...

M&A news last week featured French pharma major Sanofi announcing an agreement to acquire US vaccine maker Dynavax ...

Seattle, USA-based biotech Omeros Corp saw its shares leap 75.5% to $15.36 by close of trading Wednesday, as it revealed that ...

By Emma Banks, chief executive at ramarketing If I had to describe 2025 in one phrase, it would be this: a year of two halves ...

China’s rise as a biopharma innovator is reshaping global drug development, underpinned by regulatory reform and a rapidly ...

French pharma major Sanofi (Euronext: SAN) has received a Complete Response Letter (CRL) from the US regulator for ...